“…We and others have shown that kidney transplant recipients (KTR) exhibit a reduced immune response with a seroconversion (SC) rate <50% after a regular 2-dose mRNA SARS-CoV-2 vaccination regimen ( 1 , 2 ). Very limited data on a heterologous 3-dose vaccination with the vector vaccine Ad26COVS1 are available in this patient group.…”